BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Burrill & Company Advises Samsung Corporation in Biosimilars Joint Venture Agreement With Biogen Idec, Inc. (California) (BIIB)


12/7/2011 10:13:00 AM

SAN FRANCISCO, CA--(Marketwire - December 07, 2011) -

Samsung and Biogen Idec said that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture, and market biosimilars. The Merchant Banking Group of Burrill & Company, a diversified global financial services firm focused on the life sciences industry, acted as advisor to Samsung in the agreement.

"This agreement is a perfect example of how Burrill & Company's merchant bank is leveraging the firm's global network to serve our client base," says Stephen Hurly, CEO of Burrill Merchant Banking. "With a team of dedicated life sciences deal makers in developed and emerging markets, we are uniquely positioned to help our clients capitalize on opportunities around the world."

Under the agreement Samsung will take a leading role in the joint venture, with Biogen Idec contributing its expertise in protein engineering and biologics manufacturing. Samsung will contribute $255 million of the $300 million for an 85 percent stake and Biogen Idec will contribute $45 million for a 15 percent stake in the joint venture. The joint venture, which will be based in Korea, will contract with Biogen Idec and Samsung Biologics for technical development and manufacturing services. The joint venture will not pursue biosimilars of Biogen Idec's proprietary products.

"Companies have great value locked up in their products and expertise that is not being captured today because of their inability to exploit opportunities in foreign markets," says G. Steven Burrill, CEO of Burrill & Company. "As rising economies create new demand, Burrill & Company is working with life sciences companies to capitalize on untapped value they may not even realize they possess."

About Burrill & Company

Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With more than $1 billion in assets under management, the firm's businesses include venture capital, private equity, merchant banking, and media. By leveraging the scientific and business networks of its investment team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, management expertise, insight, market intelligence, and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe, and Asia. For more information visit: www.burrillandco.com.


Contact:
Daniel Levine
Managing Director
Burrill & Company
Email Contact
415-591-5449

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES